Physicians' Academy for Cardiovascular Education

Benefit with cardiac myosin activator in HFrEF

3' education - Nov. 14, 2020 - Prof. John Teerlink, MD - San Francisco, CA, USA

Educational information

This video was recorded during the virtual congress of the AHA Scientific Sessions 2020.

Faculty

Dr. John R. Teerlink is Director of Heart Failure and of the Echocardiography Laboratory at the San Francisco Veterans Affairs Medical Center in San Francisco, California and Professor of Clinical Medicine at UCSF.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of the GALACTIC-HF trial

Share this page with your colleagues and friends: